Cite

HARVARD Citation

    Lu, Y. et al. (n.d.). A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record